The Future of Life-saving Treatments

We reduce the world's organ shortage and speed up drug development by providing life science solutions that combine biology and technology.

Interim Report
January – March 2022

Continued growth in sales, improved profitability and focus on commercial synergies.

Printing the Future of Health

Our revolutionary bioprinting workflows are enabling the future of health through bioprinting of tissues and organs. Together with our new automation software from Biosero, we will enhance the user experience and speed up research and development around the world.
Play Video
See How it Works

Bico by numbers

  • Net sales Q1 2022
    0 MSEK
  • Organic growth Q1 2022
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +

press releases


We’re equipping hundreds of labs with technologies that fuel groundbreaking scientific breakthroughs. Explore a selection of products within BICO.

Industry Leaders Shaping the Future of Health With Our Products

BICO News Feed

Discover the latest news from our business areas.


05/18/22Interim report January-March 2022
08/24/22Interim report January-June 2022
11/09/22Interim report January-September 2022
02/22/23Year-end report 2022

BICO in the press

12/17/21 Genetic Engineering & Biotechnology NewsBICO Group Expands into Software with Up-to-$165M Biosero Acquisition
12/16/21 3D Printing Media NetworkBICO Endorses FDA Modernization Act of 2021
11/26/21 Nordic Life Science NewsThese are the 5 nominees for the SwedenBIO Award
09/01/21 Genetic Engineering & Biotechnology NewsBuying Spree: Rebranded BICO Bets Big on “Bioconvergence”
08/31/21 San Diego Business JournalAdvanced BioMatrix Acquired by BICO for $15M
08/20/21 Nordic Life Science NewsCELLINK rebrands itself to BICO
We are BICO

We extend the boundaries of what’s possible to give people better and healthier lives.

We are BICO

We extend the boundaries of what’s possible to give people better and healthier lives.